Washington Post – An opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.